Dover’s growth in liquid cooling and pharma pumps offsets some risk, but stretched valuation and macro headwinds remain. Read ...

Alliance Resource Partners' Q1 2025 results show steady growth despite challenges in Appalachian operations. Check out why I ...

GV (formerly Google Ventures): Alphabet's venture capital arm, investing in numerous early-stage technology companies.

Orkla's focus on core business and asset divestment has been driving stock gains. Click here to read the full investment ...

Coca-Cola's high profitability and effective investment strategy support its long-term growth. Read what makes KO stock a ...

Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

LCI Industries has seen margins come in below long-term averages. Click here to read more about LCII stock and why it is a ...

It remains to be seen how the new management team will lead Patriot National Bancorp. Click here to read why PNBK stock is a ...

Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See ...

The Bloomberg US Credit Index returned +2.36% for the quarter. A bull-steepening UST yield curve more than offset the ...

Nvidia faces competition from high-tech majors, risking market share and profit margins. Read why I remain neutral on NVDA ...

FFA offers a blend of capital appreciation and consistent income, with a 7.3% dividend yield. Click here to read why I rate ...